SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Allos Therapeutics, Inc.' Marketing Authorisation Application (MAA) for FOLOTYN(R) Accepted for Review by European Medicines Evaluation Agency